Changes in AXL and/or MITF melanoma subpopulations in patients receiving immunotherapy
Overall, this study suggests that more differentiated MITF+ tumors are efficiently targeted by immunotherapy, while AXL+ tumor cells may be more resistant, analogous to their response to targeted therapy.
Authors
- Sudhir Kumar Chauhan (ORCID: https://orcid.org/0000-0002-7931-8518)
- Jenny Bulgarelli (ORCID: https://orcid.org/0000-0002-6551-0189)
- Ragnhild Reehorst Lereim (ORCID: https://orcid.org/0000-0002-8404-7476)
- Davide Angeli (ORCID: https://orcid.org/0000-0002-8855-0829)
- Massimo Guidoboni (ORCID: https://orcid.org/0000-0001-7703-790X)
- Marcella Willemsen (ORCID: https://orcid.org/0000-0003-3376-6734)
- Rosalie M. Luiten (ORCID: https://orcid.org/0000-0002-0800-0721)
- Irwin Davidson (ORCID: https://orcid.org/0000-0001-5533-1171)
- Jon Amund Kyte (ORCID: https://orcid.org/0000-0002-2854-3694)
- G. Grisendi
- Gabrielle Krebbers
- Walbert J. Bakker (ORCID: https://orcid.org/0000-0002-6723-8764)
Institutions
- University of Modena and Reggio Emilia (IT)
- Oslo University Hospital (NO)
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- University of Ferrara (IT)
- Institut de génétique et de biologie moléculaire et cellulaire (FR)
- Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IT)
- Amsterdam University Medical Centers (NL)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Publication Details
- Journal
- Immuno-Oncology Technology
- Published
- 2024-11-15
- DOI
- https://doi.org/10.1016/j.iotech.2024.101009
- Citations
- 5
- Primary Topic
- Phagocytosis and Immune Regulation
- Type
- article
- Field-Weighted Citation Impact
- 1.20
Funders
- Helse- og Omsorgsdepartementet